Simparica Trio 1.44 mg (Moxidectin TABLET (CHEWABLE)) 1.44 MG

Simparica Trio 1.44 mg chewable tablets provide broad-spectrum parasite protection for dogs. This oral medication combines moxidectin with other active ingredients to target fleas, ticks, heartworms, and intestinal parasites. Ideal for pet owners seeking comprehensive parasite control in a single dose.

Strength

1.44 MG

Manufacturer / TM Owner

ZOETIS CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Simparica Trio 1.44 mg chewable tablets are designed to protect dogs from various parasites. This medication is used for the prevention of flea and tick infestations, as well as the treatment and control of heartworm disease. It also helps manage certain intestinal parasites, making it a versatile option for comprehensive parasite protection in dogs.

Side Effects

When administered, Simparica Trio 1.44 mg chewable tablets work to eliminate and prevent the development of fleas, ticks, and other parasites. Pet owners may notice a reduction in itching and irritation as the medication takes effect. The chewable form makes it easy to administer, ensuring pets receive the necessary protection without stress.

Precautions & Warnings

Always follow the guidance of a veterinarian when using Simparica Trio 1.44 mg chewable tablets. Ensure the correct dosage is given based on the dog's weight and health status. Keep the medication out of reach of children and other pets. Monitor your dog for any signs of adverse reactions and consult a veterinarian if concerns arise.

Avoid Interactions

Simparica Trio 1.44 mg chewable tablets may interact with other medications, so it's important to inform your veterinarian about any other treatments your dog is receiving. Avoid using this medication with other parasite control products unless directed by a veterinarian. Always consult a professional before combining treatments to ensure safety and effectiveness.

Frequently Asked Questions

Simparica Trio 1.44 mg chewable tablets are used to protect dogs from fleas, ticks, heartworms, and certain intestinal parasites.

Administer the chewable tablet orally, following the dosage instructions provided by your veterinarian.

Consult your veterinarian before using Simparica Trio 1.44 mg with other medications to avoid potential interactions.

If your dog shows signs of an adverse reaction, contact your veterinarian immediately for guidance.

Simparica Trio 1.44 mg is generally safe for dogs, but always follow your veterinarian's advice regarding its use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.